by Richard Daverman, PhD
November 26, 2013 -- Shanghai Institute of Materia Medica (SIMM) will form a cancer-focused collaboration with Crown Bioscience. As a first step, the two entities will build the world’s largest mouse clinical trial center by combining their patient-derived xenograft (PDX) models. Then, using Crown’s oncology discovery and translational capabilities, the center will accelerate development of SIMM’s oncology drug candidates. Crown is a US-headquartered CRO with its lab operations in China. More details....
Help employers find you! Check out all the jobs and post your resume.
